Treatment
Medication clinical trials
We’re tracking 7,446 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07635719Recruiting
Comparing surgical tools for tonsil and adenoid removal
This study compares different surgical tools used during tonsil and adenoid removal surgery in children. The goal is to see which tool works best and is safest for this common pediatric surgery.
The Bronx, New YorkAges 1–18 - NCT06431620Recruiting
Thyroid cancer scan with help of a special hormone
This study tests if a man-made hormone (rhTSH) can make radioactive iodine therapy more effective for people with advanced thyroid cancer that has come back or spread. It aims to see if it helps find and treat cancer that doesn't respond well to standard radioactive iodine.
Nanjing, JiangsuAges 18–75 - NCT06424314Recruiting
Trial on why some patients fail to come off a ventilator
This trial is studying why some people have trouble coming off a breathing machine (ventilator). It's for patients who've been on a ventilator for at least 2 days and don't have certain other conditions.
Guangzhou, GuangdongAges 18 years+ - NCT07244419RecruitingEarly Phase 1
Preventing stem cell transplant rejection in children
This early-phase trial tests a medication to prevent rejection of donated stem cells in children. It's for patients who are at high risk for their transplant to fail.
Cincinnati, OhioAges Any age - NCT06548802RecruitingPhase 1/Phase 2
Baricitinib for lung injury after brain bleed
This trial tests a pill called baricitinib to see if it helps people recover from lung injury after a brain bleed. It is for patients who need a breathing machine due to ARDS that started within a week of the bleed.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07213544RecruitingPhase 4
Comparing two sedatives for laser burn treatments
This trial tests if remimazolam or propofol works better for people getting two laser treatments for burn scars on different days. It aims to find which drug helps you relax more comfortably during the procedure.
Charleston, South CarolinaAges 18 years+ - NCT06404905RecruitingPhase 1
Testing BT02 for advanced solid tumors
This trial tests a new drug called BT02 for people with advanced solid tumors who have not had any cancer treatment before. It aims to see if BT02 is safe and how well it works.
Beijing, BiejingAges 18–75 - NCT06395389Recruiting
A brief program to help young adults cut back on cannabis
This trial tests a short, one-time program designed to help people ages 18-25 who use cannabis frequently (at least 20 days per month) reduce their use. It may be a good fit if you're not already in treatment and are thinking about making a change.
Charleston, South CarolinaAges 18–25 - NCT05380349RecruitingEarly Phase 1
Personalized testing of drugs for glioblastoma stem cells
This early trial tries to find which medicines might work best for your specific glioblastoma, by testing drugs on cancer “stem cell” samples. If the test finds promising drug options, it may guide a more personalized treatment approach.
Seattle, WashingtonAges 18 years+ - NCT07676435RecruitingPhase 2
Fisetin trial for healthy lung aging
This study tests whether a natural supplement called fisetin can help slow lung decline in older adults who are either lifelong nonsmokers or long-term smokers. You would take fisetin or a placebo for a period and be monitored regularly.
Los Angeles, CaliforniaAges 60 years+ - NCT06382012RecruitingPhase 2/Phase 3
Fosaprepitant for nausea in the emergency room
This study tests if a drug called fosaprepitant can help people in the emergency room whose nausea and vomiting don't improve with standard medicine. It may be an option if you still feel sick 2 hours after your first nausea treatment.
The Bronx, New YorkAges 18 years+ - NCT07092176Recruiting
Steady Stride fall prevention study for older adults
This study compares a new fall-prevention program, Steady Stride, to the usual care for older adults who have fallen recently. It aims to help you stay steady and avoid future falls so you can keep living independently.
Baltimore, MarylandAges 65 years+ - NCT06543992RecruitingPhase 2
Chemotherapy for breast cancer that spread to the brain lining
This trial tests a combination of two chemotherapy drugs (thiotepa and methotrexate) given directly into the fluid around your brain and spine through a small implanted device. It aims to treat breast cancer that has spread to the lining of the brain or spinal cord.
Nanjing, JiangsuAges 18–75 - NCT05354375RecruitingPhase 1
PSMA-targeted CAR-T cell therapy for resistant prostate cancer
This Phase 1 study tests whether lab-made immune cells (CAR-T) that target PSMA can treat prostate cancer that keeps growing despite hormone treatment. It may help people whose disease no longer responds to standard endocrine (hormone-blocking) therapy.
Xuzhou, JiangsuAges 18–75 - NCT06340217Recruiting
Washed Microbiota Transplant for Diabetic Stomach Paralysis
This trial tests a new treatment called washed microbiota transplantation for diabetic gastroparesis, a condition where the stomach empties slowly due to diabetes. If you have had diabetes for over a year and struggle with bloating or feeling full quickly, this study may explore whether transplanting healthy gut bacteria can help relieve your symptoms.
Nanjing, JiangsuAges 18–100 - NCT06349486Recruiting
Comparing new treatments for H. pylori infection
This trial compares three different medication combinations to see which works best for treating H. pylori infection. If you have H. pylori and haven't been treated yet, you may be able to join.
Kaohsiung CityAges 18 years+ - NCT06615141Recruiting
Virtual reality for arm recovery after stroke
This trial tests whether a more immersive virtual reality (VR) game or a simpler VR game better helps improve arm movement in people who have had a stroke and still have arm weakness. You will use a VR headset or screen to do exercises, and researchers will see which approach works best.
AjmanAges 28–55 - NCT06340711RecruitingPhase 2
Gene therapy plus Keytruda for advanced stomach or esophageal cancer
This study tests a new type of gene therapy (OBP-301) injected directly into the tumor, combined with the immunotherapy drug Keytruda (pembrolizumab), for people with advanced stomach, junction, or esophageal cancer. Researchers want to see if this combination can help when standard treatments have stopped working.
New York, New YorkAges 18 years+ - NCT06332040RecruitingPhase 4
Gentamicin in the bladder to prevent catheter infections
This trial tests whether giving a low dose of the antibiotic gentamicin directly into the bladder through the catheter can prevent infections in people who are critically ill and have a Foley catheter. If you qualify, you might receive this treatment to help reduce the risk of a catheter-related urinary tract infection.
Phoenix, ArizonaAges 18 years+ - NCT06760364RecruitingPhase 1
CHT102 for Advanced Pancreatic Cancer with Mesothelin
This trial tests a new treatment called CHT102 for people with advanced pancreatic cancer that has a specific protein (mesothelin) on their tumor cells. It's for those who have already tried standard treatments without success or couldn't tolerate them.
TianjinAges 18–70 - NCT06321848Recruiting
Ultrasound to guide weaning from a breathing machine
This trial uses ultrasound pictures of the heart, lungs, and diaphragm (a muscle that helps you breathe) to help doctors decide when to take a patient off a breathing machine after surgery. It may help make the weaning process safer and more personalized.
HanoiAges 18 years+ - NCT06876831Recruiting
Lung cancer screening for current and recent smokers
This study aims to create a program to help people get screened for lung cancer while they are in the hospital. It is for people who are at higher risk due to their age and smoking history.
New York, New YorkAges 50–80 - NCT06198491Enrolling by invitation
HPV education study for women
This study tests how learning more about HPV affects women's beliefs about the virus. It may help you make informed health decisions.
Odunpazari, EskişehirAges 18 years+ - NCT06276088Recruiting
SAA1 levels to predict cancer immunotherapy response
This trial measures a protein called SAA1 in your blood and tumor tissue to see if it can predict how your cancer will respond to immunotherapy. It aims to understand why some patients have rapid tumor growth after treatment.
Guangzhou, GuangdongAges 18 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,446 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.